DaVita Inc. (NYSE:DVA) is one of the 10 Best Long-Term Stocks to Buy Now According to Warren Buffett.

DaVita Inc. (NYSE:DVA) is a healthcare company that caters to the needs of people suffering from kidney ailments. Another long-term Warren Buffet stock pick, Berkshire first disclosed a stake in the firm in the fourth quarter of 2011. Back then, the firm disclosed holding 5.3 million shares that were worth $203 million. The number of shares jumped considerably by the next quarter, when Berkshire held 12 million shares that were worth $541 million. By Q4 2014, Warren Buffett’s firm had held 38.6 million shares and was stuck at this level until Q4 2019. As of the first quarter of 2026, Berkshire disclosed holding 30 million shares that were worth $4.6 billion.

Warren Buffett's Berkshire Hathaway Has Held DaVita Inc. (DVA) Since 2011

Image by drobotdean on Freepik

Deutsche Bank discussed DaVita Inc. (NYSE:DVA)’s shares on May 6th when it bumped the rating to Buy from Hold and raised the share price target to $220 from $216. The coverage followed the firm’s first quarter earnings, which saw it post $417.59 in revenue per treatment to beat analyst estimates. During the quarter, DaVita Inc. (NYSE:DVA)’s operating income was $482 million.

While we acknowledge the risk and potential of DVA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than DVA and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1